Citigroup’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,985
| Closed | -$22.2K | – | 5041 |
|
|
2025
Q1 | $22.2K | Sell |
13,985
-1,277
| -8% | -$2.03K | ﹤0.01% | 4297 |
|
|
2024
Q4 | $43.2K | Buy |
15,262
+2,738
| +22% | +$7.75K | ﹤0.01% | 4277 |
|
|
2024
Q3 | $49K | Buy |
12,524
+8,676
| +225% | +$33.9K | ﹤0.01% | 4245 |
|
|
2024
Q2 | $30.8K | Buy |
+3,848
| New | +$30.8K | ﹤0.01% | 4117 |
|